85 related articles for article (PubMed ID: 9515166)
1. Purification and physical characterization of cloned human cAMP phosphodiesterases PDE-4D and -4C.
Saldou N; Baecker PA; Li B; Yuan Z; Obernolte R; Ratzliff J; Osen E; Jarnagin K; Shelton ER
Cell Biochem Biophys; 1998; 28(2-3):187-217. PubMed ID: 9515166
[TBL] [Abstract][Full Text] [Related]
2. Characterization of phosphodiesterase 4 in guinea-pig macrophages: multiple activities, association states and sensitivity to selective inhibitors.
Kelly JJ; Barnes PJ; Giembycz MA
Br J Pharmacol; 1998 May; 124(1):129-40. PubMed ID: 9630352
[TBL] [Abstract][Full Text] [Related]
3. Characterization of two recombinant PDE3 (cGMP-inhibited cyclic nucleotide phosphodiesterase) isoforms, RcGIP1 and HcGIP2, expressed in NIH 3006 murine fibroblasts and Sf9 insect cells.
Leroy MJ; Degerman E; Taira M; Murata T; Wang LH; Movsesian MA; Meacci E; Manganiello VC
Biochemistry; 1996 Aug; 35(31):10194-202. PubMed ID: 8756484
[TBL] [Abstract][Full Text] [Related]
4. Refolding and purification of recombinant human PDE7A expressed in Escherichia coli as inclusion bodies.
Richter W; Hermsdorf T; Kronbach T; Dettmer D
Protein Expr Purif; 2002 Jun; 25(1):138-48. PubMed ID: 12071709
[TBL] [Abstract][Full Text] [Related]
5. Recombinant expression of a type IV, cAMP-specific phosphodiesterase: characterization and structure-function studies of deletion mutants.
Kovala T; Sanwal BD; Ball EH
Biochemistry; 1997 Mar; 36(10):2968-76. PubMed ID: 9062127
[TBL] [Abstract][Full Text] [Related]
6. Detailed characterization of a purified type 4 phosphodiesterase, HSPDE4B2B: differentiation of high- and low-affinity (R)-rolipram binding.
Rocque WJ; Holmes WD; Patel IR; Dougherty RW; Ittoop O; Overton L; Hoffman CR; Wisely GB; Willard DH; Luther MA
Protein Expr Purif; 1997 Mar; 9(2):191-202. PubMed ID: 9056484
[TBL] [Abstract][Full Text] [Related]
7. Identification and stabilization of large molecular weight PDE-IVs from U937 cells.
DiSanto ME; Heaslip RJ
Biochem Biophys Res Commun; 1993 Dec; 197(3):1126-31. PubMed ID: 8280127
[TBL] [Abstract][Full Text] [Related]
8. Refolding, purification, and characterization of human recombinant PDE4A constructs expressed in Escherichia coli.
Richter W; Hermsdorf T; Lilie H; Egerland U; Rudolph R; Kronbach T; Dettmer D
Protein Expr Purif; 2000 Aug; 19(3):375-83. PubMed ID: 10910728
[TBL] [Abstract][Full Text] [Related]
9. Comparison of recombinant human PDE4 isoforms: interaction with substrate and inhibitors.
Saldou N; Obernolte R; Huber A; Baecker PA; Wilhelm R; Alvarez R; Li B; Xia L; Callan O; Su C; Jarnagin K; Shelton ER
Cell Signal; 1998 Jun; 10(6):427-40. PubMed ID: 9720765
[TBL] [Abstract][Full Text] [Related]
10. Expression and characterization of deletion recombinants of two cGMP-inhibited cyclic nucleotide phosphodiesterases (PDE-3).
He R; Komas N; Ekholm D; Murata T; Taira M; Hockman S; Degerman E; Manganiello VC
Cell Biochem Biophys; 1998; 29(1-2):89-111. PubMed ID: 9631240
[TBL] [Abstract][Full Text] [Related]
11. Purification and characterization of the human PDE4A catalytic domain (PDE4A330-723) expressed in Sf9 cells.
Lario PI; Bobechko B; Bateman K; Kelly J; Vrielink A; Huang Z
Arch Biochem Biophys; 2001 Oct; 394(1):54-60. PubMed ID: 11566027
[TBL] [Abstract][Full Text] [Related]
12. Further studies on the phosphorylation-regulated cAMP-phosphodiesterase from the dimorphic fungus Mucor rouxii.
Tomes C; Kerner N; Moreno S; Passeron S
Second Messengers Phosphoproteins; 1988-1989; 12(5-6):289-99. PubMed ID: 2856114
[TBL] [Abstract][Full Text] [Related]
13. Cyclic nucleotide PDE-3. Quantitation of PDE-3A and -3B mRNAs in rat tissues by RNase protection assay.
Nagaoka T; Shirakawa T; Kasuya J; Balon TW; Manganiello VC; Fujita-Yamaguchi Y
Cell Biochem Biophys; 1998; 29(1-2):49-66. PubMed ID: 9631238
[TBL] [Abstract][Full Text] [Related]
14. Isolation and characterization of PDE8A, a novel human cAMP-specific phosphodiesterase.
Fisher DA; Smith JF; Pillar JS; St Denis SH; Cheng JB
Biochem Biophys Res Commun; 1998 May; 246(3):570-7. PubMed ID: 9618252
[TBL] [Abstract][Full Text] [Related]
15. Characterization of a hormone-inducible, high affinity adenosine 3'-5'-cyclic monophosphate phosphodiesterase from the rat Sertoli cell.
Conti M; Iona S; Cuomo M; Swinnen JV; Odeh J; Svoboda ME
Biochemistry; 1995 Jun; 34(25):7979-87. PubMed ID: 7794911
[TBL] [Abstract][Full Text] [Related]
16. Crystal structure of human phosphodiesterase 3B: atomic basis for substrate and inhibitor specificity.
Scapin G; Patel SB; Chung C; Varnerin JP; Edmondson SD; Mastracchio A; Parmee ER; Singh SB; Becker JW; Van der Ploeg LH; Tota MR
Biochemistry; 2004 May; 43(20):6091-100. PubMed ID: 15147193
[TBL] [Abstract][Full Text] [Related]
17. Expression, refolding, and purification of recombinant human phosphodiesterase 3B: definition of the N-terminus of the catalytic core.
Varnerin JP; Chung CC; Patel SB; Scapin G; Parmee ER; Morin NR; MacNeil DJ; Cully DF; Van der Ploeg LH; Tota MR
Protein Expr Purif; 2004 Jun; 35(2):225-36. PubMed ID: 15135397
[TBL] [Abstract][Full Text] [Related]
18. Renaturation of the catalytic domain of PDE4A expressed in Escherichia coli as inclusion bodies.
Richter W; Hermsdorf T; Dettmer D
Methods Mol Biol; 2005; 307():155-65. PubMed ID: 15988062
[TBL] [Abstract][Full Text] [Related]
19. Characterization of CHO-K1 cells stably expressing PDE-IV enzymes. Whole-cell cAMP determinations vs broken-cell enzymatic assays.
Pon DJ; Plant M; Tkach J; Boulet L; Muise E; Allen RA; Rodger IW
Cell Biochem Biophys; 1998; 29(1-2):159-78. PubMed ID: 9631244
[TBL] [Abstract][Full Text] [Related]
20. Characterization of 3',5' cyclic nucleotide phosphodiesterase activity in Y79 retinoblastoma cells: absence of functional PDE6.
White JB; Thompson WJ; Pittler SJ
Mol Vis; 2004 Oct; 10():738-49. PubMed ID: 15480303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
